{
"id":"mk19_qq_q098",
"number":98,
"bookId":"qq",
"correctAnswer":"D",
"title":"Question 98",
"stimulus":[
{
"type":"p",
"hlId":"5c00b3",
"children":[
"A 48-year-old woman is seen in the office for a routine wellness evaluation. She is asymptomatic. She eats a heart-healthy diet and drinks one or two alcoholic beverages each week. She does not exercise, drink coffee, smoke cigarettes, or take vitamins or supplements. Her 10-year risk for atherosclerotic heart disease is 1.7%."
]
},
{
"type":"p",
"hlId":"b4bf0a",
"children":[
"On physical examination, blood pressure is 118/78 mm Hg. BMI is 25. The remainder of the examination is normal."
]
}
],
"prompt":[
" ",
{
"type":"p",
"hlId":"7a11cb",
"children":[
"Which of the following should be recommended to reduce this patient's risk for atherosclerotic cardiovascular disease?"
]
},
" "
],
"options":[
{
"letter":"A",
"text":{
"__html":"Eliminate dairy products"
}
},
{
"letter":"B",
"text":{
"__html":"Increase coffee consumption"
}
},
{
"letter":"C",
"text":{
"__html":"Low-dose aspirin"
}
},
{
"letter":"D",
"text":{
"__html":"150 minutes of moderate-intensity aerobic exercise weekly"
}
}
],
"keypoints":[
{
"type":"keypoint",
"hlId":"79739a",
"children":[
"Adults should engage in at least 150 minutes per week of accumulated moderate-intensity activity or 75 minutes per week of vigorous-intensity aerobic physical activity (or an equivalent combination of moderate and vigorous activity) to reduce atherosclerotic cardiovascular disease risk."
]
}
],
"exposition":[
{
"type":"p",
"hlId":"6dee1b",
"children":[
"The 2019 American Heart Association (AHA)/American College of Cardiology (ACC) guideline on the primary prevention of cardiovascular disease recommends that adults be routinely counseled during health care visits to optimize a physically active lifestyle. Adults should engage in at least 150 minutes per week of accumulated moderate-intensity activity (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option D"
]
},
") or 75 minutes per week of vigorous-intensity aerobic physical activity (or an equivalent combination of moderate and vigorous activity) to reduce atherosclerotic cardiovascular disease (ASCVD) risk."
]
},
{
"type":"p",
"hlId":"2a5982",
"children":[
"Dietary guidelines recommend 3 cups of dairy (milk or foods made from milk) products daily. Consumption of dairy products may reduce the risk of total mortality, heart disease, stroke, and colorectal cancer. The patient should not be advised to eliminate dairy products from her diet (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option A"
]
},
")."
]
},
{
"type":"p",
"hlId":"822b52",
"children":[
"Three to five cups of coffee daily may decrease the incidence of uterine cancer and hepatocellular carcinoma but has no impact on the incidence of cardiovascular disease. Advising the patient to engage in moderate physical activity will be more beneficial in reducing the risk of ASCVD than increasing coffee consumption (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option B"
]
},
")."
]
},
{
"type":"p",
"hlId":"242a36",
"children":[
"The U.S. Preventive Services Task Force recommends low-dose aspirin for the primary prevention of ASCVD and colorectal cancer in willing adults aged 50 to 59 years with a 10-year ASCVD risk of 10% or higher (using the Pooled Cohort Equation risk calculator). ACC/AHA guidelines recommend that aspirin should be used infrequently in the routine primary prevention of ASCVD because of lack of net benefit; specifically, low-dose aspirin may be considered for primary prevention of ASCVD in adults aged 40 to 70 years who are at higher ASCVD risk but not at increased bleeding risk. This patient does not have an indication for aspirin therapy (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option C"
]
},
")."
]
}
],
"relatedSection":"mk19_b_gm_s1_5_4",
"objective":{
"__html":"Reduce the risk for atherosclerotic cardiovascular disease with exercise."
},
"references":[
[
"Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140:e596-e646. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30879355",
"target":"_blank"
},
"children":[
"PMID: 30879355"
]
},
" doi:10.1161/CIR.0000000000000678"
]
],
"hospitalist":false,
"hvc":false,
"peerComparison":{
},
"hlIds":[
"5c00b3",
"b4bf0a",
"7a11cb",
"79739a",
"6dee1b",
"2a5982",
"822b52",
"242a36"
]
}